- uOttawa multidisciplinary team has built new hydrogels from synthetic peptides that can be customized as needed - a defining hallmark in the emerging era of personalized medicine. - Offers game-changing potential to impact future biomedical applications, from sealing traumatic wounds to closing surgical incisions. - Bonding strength is comparable to commercially available tissue adhesives.

Los Angeles, CA –February 23, 2026 – Dr. Vadim Jucaud, Principal Investigator and Assistant Professor at the Terasaki Institute, with Co-Principal Investigator Angeles Baquerizo, MD, PhD, FACS, FAASLD have been awarded an NIH R21 research grant to develop a first-of-its-kind organ-on-a-chip platform to study immune rejection in pig-to-human liver transplantation. The project tackles one of the most pressing challenges in modern transplantation medicine: advancing xenotransplantation toward safe and effective clinical use.

Having a dog, cat or other pet can help older adults stay active and maintain a sense of purpose, but pet-related costs may increasingly strain their budgets, a new poll suggests.

By studying a bacterium responsible for a severe heart infection, the scientists show that disrupting bacterial communication can be associated with adverse clinical outcomes. Published in Nature Communications, these findings open the door to more targeted – and potentially more effective – therapeutic strategies against this type of infection. A team from NTU’s SCELSE (Singapore Centre for Environmental Life Sciences and Engineering), a multidisciplinary biofilm and microbiome research centre, and UNIGE’s Faculty of Medicine is challenging a widely held assumption in infectious disease research: that blocking bacterial communication is always beneficial. Scientists found that when Enterococcus faecalis can no longer communicate with neighbouring bacteria, it forms larger, more resilient biofilms on heart valves, resulting in more severe clinical outcomes.